Chromatin/Epigenetics

Epigenetics is the heritable modifications in gene expression that is not associated with changes in DNA sequence. Epigenetic modifications occur mostly on DNA or on the histone octamer. There are several types of epigenetics modifications, DNA methylation by DNA-methyl transferase (DNMT) and covalent modification of histones (e.g. acetylation, methylation, phosphorylation and ubiquitination). Histone acetylation by histone acetyltransferases (HATs) is involved in transcriptional activation, whereas histone deacetylation by histone deacetylases (HDACs) is connected with transcriptional repression. Histone demethylation is associated with lysine-specific demethylase (LSD) and JmjC domain containing histone demethylase (JHDM).
The nucleosome is consisted of four histone proteins (H2A, H2B, H3, and H4), they are primary building block of chromatin. The addition and removal of specific chemical groups refers to as epigenetic marks, it regulates chromatin structure and affects gene expression. Moreover, RNA is intimately involved in the formation of a repressive chromatin state.
Epigenetic mechanism responds to environmental changes at the cellular level and thus influences cellular plasticity. Chromatin and epigenetic regulation play a significant role in the programming of the genome during development and stress response, defects in epigenetics can lead to cancer, inflammation and metabolic disorders etc.
-   A4105 M3441 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor,potent and cell-permeable A4105 M3441 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor,potent and cell-permeable
-   A4530 NU 1025Summary: PARP inhibitor,potent and novel A4530 NU 1025Summary: PARP inhibitor,potent and novel
-   B1622 SGI-10274 CitationSummary: DNMT inhibitor B1622 SGI-10274 CitationSummary: DNMT inhibitor
-   B5670 I-BET 151 hydrochloride1 CitationSummary: BET bromodomain inhibitor B5670 I-BET 151 hydrochloride1 CitationSummary: BET bromodomain inhibitor
-   C3630 Lysine-specific Demethylase Inhibitor (1C)Summary: lysine-specific demethylase Inhibitor C3630 Lysine-specific Demethylase Inhibitor (1C)Summary: lysine-specific demethylase Inhibitor
-   B6784 NSC 95397Summary: Cdc25 dual specificity phosphatases inhibitor B6784 NSC 95397Summary: Cdc25 dual specificity phosphatases inhibitor
-   A4146 CEP-337791 CitationSummary: JAK2 inhibitor,highly selective A4146 CEP-337791 CitationSummary: JAK2 inhibitor,highly selective
-   A4104 AR-42 (OSU-HDAC42)2 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor,novel and potent A4104 AR-42 (OSU-HDAC42)2 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor,novel and potent
-   A4128 PF-03814735Target: Aurora KinasesSummary: Aurora A/B inhibitor A4128 PF-03814735Target: Aurora KinasesSummary: Aurora A/B inhibitor
-   A4529 JW 55Summary: PARP domain inhibitor A4529 JW 55Summary: PARP domain inhibitor
